Search results
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga via Yahoo Finance· 3 days agoGSK Plc (NYSE:GSK) has been reportedly sued by an independent Connecticut laboratory, Valisure,...
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 3 days agoHEALTH NEWS GSK’s experimental drug for asthma met its goals in the latest trial, moving a treatment...
...Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In First Zantac Cancer...
Benzinga via AOL· 1 hour agoThe jury in Cook County, Illinois, found that Angela Valadez, an 89-year-old Illinois resident, did...
GSK Plc ADR (GSK): Worth A Small Bite At $45.15 – Stocks Register
Stocks Register· 14 hours agoGSK Plc ADR (NYSE:GSK) concluded the trading at $45.15 on Thursday, May 23 with a fall of -1.38% from its closing price on previous day. Taking a look at ...
GSK found not guilty in Zantac trial
Proactive Investors· 13 hours agoBritish pharmaceuticals big cap GSK PLC (LSE:GSK, NYSE:GSK) has won a high-stake personal injury case in the state of Illinois, US, over its heartburn...
GSK says late-stage trials of potential blockbuster asthma drug met their goals
Market Watch· 4 days agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than...
Q3 2024 EPS Estimates for GSK plc Boosted by Zacks Research (NYSE:GSK)
ETF DAILY NEWS· 19 hours agoGSK plc (NYSE:GSK – Free Report) – Analysts at Zacks Research increased their Q3 2024 earnings estimates for shares of GSK in a note ...
The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals,GSK, PTC Therapeutics and Larimar...
Zacks via Yahoo Finance· 7 hours agoEquity Research analysts discuss the latest news and events impacting stocks and the financial...
Victory for drugmakers GSK and Boehringer in $640 million Zantac cancer lawsuit
Fortune· 12 hours agoJurors on Thursday found that GSK and Boehringer weren’t liable for Angela Valadez’s injuries and that the companies had properly marketed the drug without a warning about ...
First Zantac Cancer Case to Go to Trial Ends in Win for Drugmakers
Bloomberg· 1 day agoDrugmakers GSK Plc and Boehringer Ingelheim GmbH persuaded a Chicago jury to reject a woman’s claim...
